![Stephanie Bewick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Stephanie Bewick served as the Chief Business Officer at Destiny Pharma Plc from 2021 to 2023.
Prior to that, she worked as the Vice President of Business Development at Summit Therapeutics, Inc. Dr. Bewick received an undergraduate degree from The University of Edinburgh and a doctorate from the University of Bristol.
Eerdere bekende functies van Stephanie Bewick
| Bedrijven | Functie | Einde |
|---|---|---|
| DESY PHAR | Corporate Officer/Principal | 01-03-2023 |
| SUMMIT THERAPEUTICS INC. | Corporate Officer/Principal | - |
Opleiding van Stephanie Bewick
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
6
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Destiny Pharma Plc
 Destiny Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops novel antimicrobial products | Health Technology |
Summit Therapeutics, Inc.
 Summit Therapeutics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
